Cargill has agreed to buy Diamond V.

“This acquisition strengthens Cargill’s and Diamond V’s shared vision to be a leader in creating new solutions for evolving consumer preferences for sustainable and wholesome food production,” said David MacLennan, Cargill’s chairman and chief executive officer.

Cedar Rapids, Iowa-based Diamond V has a 75-year history and global reputation for developing unique, research-proven technologies that work naturally to strengthen immunity and the digestive system to enhance animal health, performance and food safety.

The purchase will encompass all of Diamond V’s operations, including the human health business, Embria Health Sciences, and its branded product EpiCor®. Diamond V’s headquarters will remain in Cedar Rapids and the Diamond V brand will be the platform for future investments in natural solutions for safer animal food production.

Terms of the deal were not disclosed. The transaction is expected to close in January 2018, subject to regulatory approval.